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ABSTRACT 
Adenovirus-polylysine-DNA complexes were evaluated for their capacity to accomplish direct in vivo gene 
transfer to airway epithelium employing a rodent model. Binary complexes containing transferrin or adenovi-
rus, or combination complexes containing both transferrin and adenovirus, were evaluated. T h e highest in 
vitro gene transfer efficiency in primary cultures of airway epithelial cells w a s accomplished by the combina-
tion complexes. This result w a s paralleled in vivo. Transient gene expression of u p to 1 week w a s observed with 
localization of the transduced cells to the region of the small airways. These results establish the feasibility of 
this type of approach for gene therapy applications. 
OVERVIEW SUMMARY 
Conjugate vectors offer many potential advantages as vehi-
cles to accomplish direct in vivo gene transfer. In this study, 
G a o et al. used adenovirus-polylysine-DNA complexes to 
deliver reporter genes to the respiratory epithelium by the 
airway route. Transient genetic modification of airway epi-
thelial cells in situ was demonstrated. Receptor-mediated 
gene delivery strategies thus offer a potential means of ther-
apeutic modification of airway epithelium. 
INTRODUCTION 
GENETIC MODIFICATION of airway epithelium offers a poten-
tial therapeutic strategy for a variety of inherited and ac-
quired pulmonary disorders. Because it has not yet been feasi-
ble to reimplant airway epithelial cells modified ex vivo, 
delivery of the heterologous genetic material must occur by 
direct in vivo transducfion ofthe target cell in situ. The access to 
airway epithelium offered by the anatomy of the tracheobron-
chial tree suggests that in vivo gene transfer be accomplished by 
direct delivery via the airway route. The low proliferative rate 
ofthe airway epithelium (Bolduc and Reid, 1976) requires that 
candidate vectors be capable of gene transfer to a nonreplicating 
cellular target (Engelhardt and Wilson, 1992). 
Foreign gene expression in airway epithelium has been dem-
onstrated after direct in vivo delivery employing lipofection 
(Brigham et al., 1989; Hazinski et al., 1991; Yoshimura et al., 
1992) and recombinant adenoviruses (Rosenfeld et al., 1991, 
1992). For practical application in therapeutic protocols, how-
ever, lipofection may be limited by its cellular toxicity (Feigner 
etal., 1987; Malone etal., 1989). In addition, this vector lacks 
cell-specific tropism. Nonspecific delivery after topical admin-
istration via the airway route may be potentially deleterious in 
settings where cell-specific gene expression is required. Direct 
in vivo delivery employing a recombinant derivative of the 
respiratory tropic adenovirus offers a more efficient vector sys-
tem (Rosenfeld et al., 1992). Potential safety hazards, how-
ever, derive from the obligatory codelivery of gene elements of 
the parent virus. In this regard, recombinant adenovunis vectors 
containing deletions of the early gene regions ElA/E IB have 
been shown to be associated with expression of viral late genes 
as well as limited viral replication (Nevins, 1981; Gaynor and 
Berk, 1983; Imperiale eta/., 1984). 
As an altemative to these approaches, w e have explored the 
utility of using adenovirus-polylysine-DNA complexes to ac-
complish direct in vivo gene delivery to the respiratory epithe-
lium. This vector system offers several potential advantages for 
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in vivo applications (Wu and W u , 1988; Wagner et al., 1990; 
Zenke et al., 1990; Cotton et al., 1991). These advantages 
include a design plasticity that permits the potential to ac-
complish cell-specific targeting. As entry is via a cellular 
intemalization pathway, complexes may be administered on a 
continuous or repetitive basis. In addition, adenovims-polyl-
ysine-DNA complexes have been constmcted that possess ex-
tremely high in vitro gene transfer efficiencies. 
W e have previously shown that gene transfer efficiency via 
the receptor-mediated pathway can be dramatically improved 
by incorporation of an adenovims moiety into the design of the 
complex (Curiel et al., 1992; Wagner et al., 1992). In this 
configuration, the adenovims functions to allow escape of the 
conjugate-DNA complex from endosomes. Because this effect 
of adenovims is mediated by viral capsid proteins and is inde-
pendent of viral gene expression (Pastan et al., 1986), it is 
possible to take measures to inactivate the adenoviral genome. 
Thus, a combination of genomic deletions and psoralen plus 
UV-irradiation can be used to minimize the potential safety 
hazards deriving from the presence of viral gene elements (Cot-
ten era/., 1992). 
In the present work, we show that we can accomplish direct 
in vivo gene transfer to the respiratory epithelium in a rodent 
model using adenovims-polylysine-DNA complexes. This es-
tablishes the feasibility of this approach as a method to accom-
plish transient gene expression in the respiratory epithelium. 
The capacity to achieve genetic modification of the airway 
epithelial cells in situ offers a potential strategy to accomplish 
gene therapy for disorders afflicting the airway epithelium. 
Gene transfer to primary cultures of cotton rat airway 
epithelial cells 
Cultures of cotton rat airway epithelial cells were prepared by 
described methods (Van Scott et al., 1986). Dissociated cells 
were harvested, washed three times with F12-7X media, and 
plated at a density of 5.0 x 10^ cells/dish in 3-cm tissue culture 
dishes. Cells were maintained in F12-7X media and utilized for 
gene transfer experiments when they achieved 5 0 - 7 5 % conflu-
ency. This usually required 2-3 days. For gene transfer experi-
ments, the formed complexes were delivered directly to the 
cells and incubated for 24 hr. Complexes evaluated included 
human transferrin-polylysine (hTfpL), adenovirus-polylysine 
(AdpL), and human transferrin-adenovims-polylysine (hTfpL/ 
AdpL). After incubation, cells were either lysed and evaluated 
for luciferase gene expression by described methods (Brasier et 
al., 1989) or stained for P-galactosidase expression utilizing 
X-gal (MacGregor and Caskey, 1989). For luciferase assays 
indicating net gene expression, epithelial cells in primary cul-
ture were treated with complexes containing the reporter plas-
mid D N A pCLuc4 (6.0 |jig). For p-galactosidase assays indicat-
ing in situ gene expression, cells were treated with complexes 
containing the reporter plasmid D N A p C M V p (6.0 p-g). 
Gene transfer to cotton rat airway epithelium in vivo 
Formed complexes were delivered to cotton rats via the intra-
tracheal route. For analysis of relative in vivo transfer effi-
MATERIALS AND METHODS 
Preparation of gene transfer vectors 
Human transferrin-polylysine-DNA complexes (hTfpL) 
were prepared by combination of (8.0 |xg) human transferrin-
polylysine (Serva Biochemical) in 150 p.1 of NaCl 150 m M / 
H E P E S 20 m M p H 7.3 (HBS) plus 6.0 |jig of plasmid D N A in 
350 p-I of H B S followed by 30 min incubation at room temper-
ature. The adenovims-component complexes were of two 
types: binary complexes that contained adenovims linked to 
polylysine-DNA (AdpL) and combination complexes that con-
tained adenovims plus human transferrin linked to polylysine-
D N A (hTfpL/AdpL). The adenoviral component complexes 
were prepared utilizing the chimeric adenovirus P202 linked to 
polylysine by an antibody bridge (Curiel et al., 1992) or the 
replication-incompetent adenovims rf/312 linked to polylysine 
by a chemical bridge consisting of biotin and streptavidin (bAd) 
(Wagner et al., 1992). In the latter instance, the vims was 
further inactivated by treatment with psoralen plus U V irradia-
tion (Cotten et al., 1992) prior to complex formation. The 
reporter plasmid D N A pCLuc4 was used for assays of net gene 
expression. This plasmid contains the firefly luciferase gene 
under the transcriptional control ofthe cytomegalovims ( C M V ) 
enhancer/early promoter. The reporter plasmid D N A p C M V p 
was used for assays of localized gene expression. This plasmid 
contains the bacterial lacZ (P-galactosidase expressing) gene 
under the transcription control of the C M V enhancer/early pro-
moter. 
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FIG. 1. Relative levels of net gene transfer to cotton rat airway 
epithelium in primary culture. The firefly luciferase reporter 
gene containing plasmid pCLuc4 was used to form conjugate-
D N A complexes, which were delivered to airway epithelial 
cells harvested from cotton rat tracheas. Cell lysates were 
evaluated for luciferase gene expression after 24 hr. The 
vector species included human transferrin-polylysine-DNA 
complexes (hTfpL), adenovirus-polylysine-DNA complexes 
(AdpL), and human transferrin-adenovims-polylysine-DNA 
complexes (hTfpL/AdpL). Background indicates evaluation of 
unmodified cells. Ordinate represents luciferase gene expres-
sion as light units per 25 p,g of total protein derived from 
cellular lysates. Experiments were performed three to four 
times each and results are reported as mean ± S E M . 
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FIG. 2. Relative transduction frequency of cotton rat airway epithelium in primary culmre. The lacZ histologic reporter containing 
plasmid p C M V p was used to form conjugate-DNA complexes and delivered to primary cultures of cotton rat airway epithelia as before. 
Cells were evaluated for expression ofthe reporter gene by staining with X-gal at 24 hr. Results are shown for primary cultures of cotton 
rat epithelial cells transduced with the various complex species: A. hTfpL; B. AdpL; C. hTfpL/AdpL. Magnification, 320x 
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ciency, the evaluated complexes included human transferrin-
polylysine (hTfpL), adenovims-polylysine (AdpL), and human 
transferrin-adenovims-polylysine (hTfpL/AdpL). These com-
plexes contained the reporter plasmid D N A pCLuc4. For histo-
logic localization of in vivo gene transfer, the human transfer-
rin-adenovims-polylysine complexes (hTfpL/AdpL) contained 
the lacZ reporter plasmid D N A p C M V p . For evaluation of 
temporal pattem of in vivo gene expression, the complex uti-
lized was the human transferrin-adenovims-polylysine com-
plex containing replication-defective adenoviras rf/312 that had 
been inactivated by psoralen plus UV-irradiation (hTfpL/ 
bAdpL). These complexes contained the reporter plasmid D N A 
pCLuc4. Animals were anesthetized with methoxyflurane. Af-
ter a vertical incision in the ventral aspect of the neck, the 
trachea was isolated by blunt dissection. With the animal in-
clined at a 45° angle, the complexes (250-300 p,l; 3.0 p,g of 
plasmid D N A ) were injected directiy into the trachea under 
direct visualization. At indicated times post-injection, the ani-
mals were sacrificed by C O j inhalation and trachea and lung 
were harvested en bloc after perfusion of pulmonary vessels in 
situ with cold phosphate-buffered saline (PBS). For luciferase 
assays, the lung blocks were homogenized in extraction buffer, 
and lysates were standardized for total protein content and eval-
uated for luciferase gene expression as described (Brasier etal., 
1989). For the p-galactosidase assays, frozen sections of intact 
unperfused lung were prepared and stained with X-gal as de-
scribed (MacGregor and Caskey, 1989). 
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FIG. 3. Relative levels of net gene transfer to cotton rat airway 
epithelium in vivo. The firefly luciferase reporter gene contain-
ing plasmid pCLuc4 was used to form conjugate-DNA com-
plexes, which were delivered to cotton rats via injection by the 
intratracheal route. Lungs were harvested and lysates were 
evaluated for luciferase gene expression after 24 hr. Vector 
species included human transferrin-polylysine-DNA com-
plexes (hTfpL), adenovims-polylysine-DNA complexes (AdpL), 
and human transferrin-adenovuus-polylysine-DNA complexes 
(hTfpL/AdpL). Background indicates evaluation of lungs irom 
untreated animals. Ordinate represents luciferase gene expres-
sion as light units per 1250 p,g total protein derived from lung 
lysates. Experiments were performed three to four times each 
and results are expressed as mean ± S E M . 
Gene transfer to cotton rat airway epithelial cells in 
primary culture via receptor-mediated delivery 
The cotton rat (Sigmodon hispidus) has been shown to be an 
animal model of human adenoviral lung disease (Pacini et al., 
1984) and therefore was employed as a target for gene transfer 
to respiratory epithelial cells employing adenovims-poly-
lysine-DNA complexes. The gene transfer efficiency of the 
various conjugate designs was initially evaluated by transfect-
ing primary cultures of cotton rat airway epithelial cells with a 
firefly luciferase reporter plasmid pCLuc4 (Fig. 1). Compari-
son was made among simple binary complexes that intemalize 
through the transfenin pathway (hTfpL), binary adeno viral-
component complexes intemalizing via the adenoviral pathway 
(AdpL), and combination complexes possessing both transfer-
rin and adenoviral domains and thus the capacity to intemalize 
by both pathways (hTfpL/AdpL). In this analysis, the cotton rat 
airway epithelium in primary culture showed only a very low 
level of luciferase gene expression employing the hTfpL com-
plexes. This is consistent with the fact that this conjugate spe-
cies may be entrapped within cellular endosomes, owing to the 
lack of a specific cell vesicle escape mechanism (Curiel et al., 
1991, 1992; Wagner era/., 1992). The adenovims-component 
binary complexes (AdpL) exhibited significantly greater gene 
expression. This was further augmented by the inclusion of a 
second ligand domain in the combination configuration (hTfpL/ 
AdpL). 
To determine if the relative levels of net gene expression 
correlated with transduction frequency, w e next evaluated the 
percentage of cells transduced with the various complex species 
employing the lacZ histologic reporter plasmid p C M V p , which 
encodes the bacterial p-galactosidase gene (Fig. 2). In this 
analysis, it could be seen that the relative levels of net gene 
expression observed in the luciferase assay reflected the relative 
numbers of cells transduced. Thus, the hTfpL-modified airway 
epithelium in primary culture exhibited < 1 % transduction fre-
quency, the A d p L complexes on the order of 20-30%, and the 
hTfpL/AdpL combination complexes greater than 5 0 % modi-
fied cells. 
Gene transfer to cotton rat airway epithelia in vivo via 
receptor-mediated delivery 
The various complex species were next delivered to the air-
way epithelium ofthe rodent model by the airway route. Initial 
evaluation determined the relative in vivo gene transfer effi-
ciency of the complexes employing the luciferase reporter (Fig. 
3). In this analysis, the relative efficiency of the complexes in 
vivo paralleled the finding in the analysis of primary cultures of 
airway epithelial cells. Thus, the hTfpL complexes mediated 
levels of luciferase gene expression in lung extract only slightiy 
above levels observed in unmodified lung. Higher levels were 
achieved by the AdpL complexes and the highest levels were 
achieved by the hTfpL/AdpL combination complexes. Whereas 
the magnitude of net gene expression observed in vivo was of a 
lower order than that observed for the in vitro experiments, no 
conclusions may be drawn as relates to relative efficiency in 
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FIG. 4. Localization of heterologous gene expression in cotton rat airway epithelium. The lacZ histologic reporter containing 
plasmid p C M V p was used to form human transferrin-adenovims-polylysine-DNA (hTfpL/AdpL) complexes and delivered to 
cotton rats via injection by the intratracheal route. At 24 hr, 14-p,m-thick frozen sections of harvested lungs were evaluated for 
expression of the reporter gene by stain with X-gal and counterstained with Nuclesu- Fast Red. Results are shown for cotton rats 
treated with hTfpL/AdpL complexes containing an irrelevant non-/acZ plasmid Rc/RSV or p C M V p containing the lacZ reporter 
plasmid. A. Bronchiolus of cotton rat treated with hTfpL/AdpL complexes containing plasmid D N A pRc/RSV. B. Bronchus of 
cotton rat treated with hTfpL/AdpL complexes containing plasmid D N A p C M V p . C. Distal airway region of cotton rat treated with 
hTfpL/AdpL complexes containing plasmid D N A pRc/RSV. D. Distal airway region of cotton rat treated with hTfpL/AdpL 
complexes containing plasmid D N A p C M V p . Magnification, 600x. E. Enlargement of P-galactosidase-positive region from 
lungs of cotton rat treated with hTfpL/AdpL complexes containing plasmid D N A p C M V p . Magnification, 1,000x. 
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FIG. 5. Time course of heterologous gene expression in cotton 
rat airway epithelium transduced with human transferrin-ade-
novims-polylysine-DNA complexes. The firefly luciferase re-
porter gene containing plasmid pCLuc4 was used to form con-
jugate-DNA complexes which were delivered to cotton rats via 
injection by the intratracheal route. The complexes (hTfpL/ 
bAdpL) were formed with human transferrin-polylysine and 
adenovirus that had been inactivated by genomic deletion and 
treatment with psoralen plus UV-irradiation. Lungs were har-
vested and lysates evaluated for luciferase gene expression at 
various time points post-injection. Ordinate represents lu-
ciferase gene expression as light units per 1,250 p-g total protein 
derived from lung lysates. Experiments were performed three to 
four times each and results were expressed as mean ± S E M . 
these two contexts. For the in vitro experiments, all of the cells 
harvested for analysis were accessible to conjugate-mediated 
gene transfer. For the in vivo experiments, the respiratory epi-
thelium accessible to transduction represented only a minor 
fraction of the harvested lung material evaluated for net gene 
expression. 
W e next evaluated in vivo transduction efficiency employing 
the lacZ histologic reporter (Fig. 4). This analysis was limited 
to the hTfpL/AdpL complex species, which exhibited the high-
est net in vivo gene transfer. Evaluation of histologic lung 
sections of animals treated in this manner demonstrated patchy 
areas of p-galactosidase activity containing multiple marked 
cells. As a control, no P-galactosidase activity could be de-
tected in animals transduced with the hTfpL/AdpL complexes 
containing an irrelevant plasmid D N A . These positive regions 
were localized to the bronchioles and distal airway region. 
Specific airway epithelial subsets modified could not be deter-
mined in this assay. 
The time course of heterologous gene expression in the air-
way epithelium was evaluated by using the luciferase reporter 
gene in combination with the hTfpL/bAdpL combination com-
plexes (Fig. 5). For this analysis, the adenovims had been 
inactivated by a combination of gene deletion and treatment 
with psoralen plus UV-irradiation (Cotten et al., 1992). This 
modification allows prolonged in vitro expression consequent 
to minimized adenoviral replication and/or gene expression. 
M a x i m u m gene expression was noted at 24 hr post-administra-
tion. There was a rapid decrease of net gene expression such 
that levels diminished to background by day 7. 
DISCUSSION 
In this preliminary report, we demonstrate the feasibility of 
accomplishing heterologous gene expression to the respiratory 
epithelium in situ employing adenoviras-polylysine-DNA 
complexes. Whereas in vivo transduction of airway epithelium 
has been obtained utilizing other vector systems, adenovims-
polylysine-DNA complexes offer several potential advantages 
for this application. Practical advantages derive from the fact 
that this vector system transports heterologous D N A bound to 
the viral capsid exterior rather than incorporated into the parent 
vims genome as is the case for recombinant adenoviral vectors 
(Berkner, 1988; Curiel ef a/., 1992). Thus, theamountof D N A 
that can be transported is not limited by packaging constraints 
of the recombinant viral system. Whereas the upper size limit of 
D N A transportable by recombinant adenoviral vectors is on the 
order of 6-8 kb (Berkner, 1988), up to 48 kb of D N A has been 
transferred utilizing the adenovims-polylysine-DNA com-
plexes (Cotten et al., 1992). In addition, the D N A is incorpo-
rated into the complexes in a sequence-independent manner. 
Gene constmcts transferred are thus not restricted to the context 
of viral regulatory controls. 
Potential advantages are also offered from a safety stand-
point. The production of recombinant adenoviral vectors re-
quires maintenance ofthe functional integrity ofthe parent viral 
genome, since the heterologous sequences are incorporated 
therein. Despite genetic maneuvers to limit the replicative ca-
pacity ofthe vectors, the ElA/E IB deletion mutants are associ-
ated with late viral gene expression and detectable viral replica-
tive capacity (Nevins, 1981; Gaynor and Berk, 1983; Imperiale 
et al., 1984; Gregory et al., 1992). In the configuration of the 
adenovims-polylysine-DNA complexes, the entry mechanism 
of the viras is exploited in a selective manner whereby viral 
gene elements are not an essential feature (Cotten et al., 1992). 
Thus, it is feasible to inactivate the parent viral genome by 
using a combination of mechanisms, including viral gene dele-
tions and psoralen plus U V irtadiation, as w e have done here. 
By extending this strategy of vector design, it is theoretically 
possible that viral gene elements may be ultimately eliminated, 
thereby creating an even safer vector. 
The marked plasticity of molecular conjugate design allowed 
the derivation of a vector with optimized in vivo gene transfer 
efficiency. The low gene transfer capacity of the hTfpL com-
plexes in vitro and in vivo is consistent with the fact that this 
species may be entrapped within the cell vesicle system after 
intemalization consequent to the lack of a specific endosome 
escape mechanism (Curiel et al., 1991, 1992; Wagner et al., 
1992). The A d p L complexes make use of the adenovims as 
both ligand domain and endosomolysis principle. These com-
plexes could thus be intemalized via adenoviral receptors and 
escape cell vesicle entrapment by virtue of adenovims-medi-
ated endosomolysis. This fact was reflected in the significantly 
augmented gene transfer capacity of these complexes. The ad-
dition of a second ligand to the complexes in the hTfpL/AdpL 
configuration allowed even greater gene transfer to occur both 
in vitro and in vivo. The fact that these complexes contain two 
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potential ligand domains allows their intemalization by both of 
these pathways. Whereas no direct comparison is made in this 
study between the in vivo gene transfer efficiency of recombi-
nant adenoviral vectors and adenovims-polylysine-DNA com-
plexes, it is noteworthy that in the case of the adenovims-
polylysine-DNA complexes the conjugate design may be 
modified such that it possesses the capacity to intemalize both 
by the adenoviral as well as altemate internalization pathways. 
A more direct comparison can be made to lipofectin whereby 
gene expression levels obtained after delivery employing the 
human transferrin-adenovirus polylysine-DNA complexes 
were two orders of magnitude greater than levels observed in a 
similar protocol utilizing the cationic liposomes (Yoshimura et 
al., 1992) (data not shown). 
The detectable in vivo gene expression mediated by the ade-
novims-polylysine D N A complexes was of a transient nature. 
This closely parallels the expression pattem noted after lipofec-
tin-mediated in vivo gene transfer to the respiratory epithelium 
(Hazinski et al., 1991). This result is not unanticipated because 
the delivered D N A would be present as a plasmid episome 
lacking replicative or integrative capacity (Wilson etal., 1992). 
In the present design, the conjugate system lacks a mechanism 
to mediate integration and thus the stable transduction fre-
quency would be expected to be low. Alternatively, attrition of 
the modified cells could explain the extinction of gene transfer 
in the lung. The fate of individual modified cells was not ad-
dressed in this study and thus the possibility of vector-associ-
ated cell toxicity could not be excluded. 
Transient genetic modification of the airway epithelium may 
be potentially beneficial in certain therapeutic contexts. For 
gene therapy of inherited disorders afflicting respiratory epithe-
lium such as cystic fibrosis (Boat et al., 1989), however, per-
manent correction of cellular targets is desirable. Application of 
transient expression systems such as molecular conjugates or 
recombinant adenovimses to achieve long-term correction 
would thus require repetitive dosing. It is unclear whether this 
would be feasible given the potential immunologic sequelae 
that may derive from this type of treatment. Thus, the incorpo-
ration of an integration mechanism within the design of the 
conjugate vector would likely enhance its utility for therapeutic 
genetic modification of airway epithelium as well as for a vari-
ety of other genetic correction applications. 
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